Back to Research
Retatrutide 30MG

Research Peptide

Retatrutide 30MG

$599.00

Purity

≥99.5%

Mol. Weight

4,196.64 g/mol

HPLC Tested
Priority Ship
USA Synthesis

Certificate of Analysis

LOT #NP-RETATR-26

View PDF

The 30 mg vial packages the same LY3437943 triple-agonist molecule in a bulk presentation intended for extended dose-titration protocols, chronic-dosing studies, and multi-arm comparative research. Its ~6-day half-life supports once-weekly dosing across long protocols. Reported research benefits: dose-dependent body weight loss exceeding dual-agonist comparators, reduction of visceral adipose tissue and hepatic steatosis (MRI-PDFF studies show substantial liver-fat clearance), improved insulin sensitivity and fasting glucose, increased basal metabolic rate via glucagon-receptor thermogenic activity, favorable shifts in ApoB and triglycerides, and sustained appetite suppression across 24–48 week protocols.

Amino Acid Sequence

39 amino acids (fatty-acid modified)

Storage

Store lyophilized peptide at -20°C in a sealed vial away from light and moisture. After reconstitution with bacteriostatic water, keep refrigerated at 2–8°C and use within 30 days. Do not freeze reconstituted solution.

For laboratory research use only. Not for human or veterinary use.

1